KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AbbVie (ABBV) Liabilities and Shareholders Equity (2016 - 2025)

Historic Liabilities and Shareholders Equity for AbbVie (ABBV) over the last 15 years, with Q3 2025 value amounting to $133.9 billion.

  • AbbVie's Liabilities and Shareholders Equity fell 664.05% to $133.9 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $542.4 billion, marking a year-over-year decrease of 466.44%. This contributed to the annual value of $135.2 billion for FY2024, which is 33.4% up from last year.
  • Per AbbVie's latest filing, its Liabilities and Shareholders Equity stood at $133.9 billion for Q3 2025, which was down 664.05% from $137.2 billion recorded in Q2 2025.
  • Over the past 5 years, AbbVie's Liabilities and Shareholders Equity peaked at $150.5 billion during Q1 2021, and registered a low of $133.9 billion during Q3 2025.
  • Moreover, its 5-year median value for Liabilities and Shareholders Equity was $141.3 billion (2022), whereas its average is $140.9 billion.
  • Its Liabilities and Shareholders Equity has fluctuated over the past 5 years, first skyrocketed by 6502.48% in 2021, then crashed by 853.67% in 2025.
  • Quarter analysis of 5 years shows AbbVie's Liabilities and Shareholders Equity stood at $146.5 billion in 2021, then decreased by 5.27% to $138.8 billion in 2022, then dropped by 2.95% to $134.7 billion in 2023, then increased by 0.33% to $135.2 billion in 2024, then decreased by 0.93% to $133.9 billion in 2025.
  • Its Liabilities and Shareholders Equity stands at $133.9 billion for Q3 2025, versus $137.2 billion for Q2 2025 and $136.2 billion for Q1 2025.